This version is for browsers with a low level of support for CSS, and is des
Home Language Selection
Home Content Area
Home Navigator
End Navigator
Baden-Württemberg integrates the compentence in biotechnology and life sciences in five regional clusters. The regions Rhein-Neckar (BioRN Network), STERN, Freiburg, Ulm and BioLAGO are successfully promoting research and development in this fields.
BioRN Network - world-famous location
The biotechnology region Rhein-Neckar is one of the best research locations in the world for molecular biology as it includes institutions such as the European Molecular Biology Laboratory (EMBL), the German Cancer Research Centre (DKFZ), the Centre for Molecular Biology Heidelberg (ZMBH), and numerous other institutes.
The region has around 80 innovative companies, most of which are active in the fields of drug development and technologies for the diagnosis and therapy of diseases, making it one of the leading biotechnology clusters in Europe: A network of short decision paths for the further development of biotechnology.
More information: BioRN Network
BioRegio STERN - one BioRegion, five locations, many advantages
With an excellent university and research landscape and the large number of innovative businesses, a successful scientific and economic dynamic develops in the STERN BioRegion. STERN stands for the initial letters of the cities and districts of Stuttgart, Tübingen, Esslingen, Reutlingen and Neckar-Alb. The STERN BioRegion focuses its research in the exciting new field of regeneration biology.
BioRegionUlm - Europe’s pacesetter for biotechnological production
BioLAGO - Life sciences at the lakeside
In 2005, BioLAGO became the fifth bioregion in Baden-Württemberg and has since been bringing together scientific institutions and companies in the Lake Constance region, thereby transforming southwest Germany into a biotech location.
BioLAGO is a cross-border network that brings together existing potential in the Lake Constance region on the borders of Germany, Switzerland, France and Austria. At present, BioLAGO consists of 80 stakeholders from research and industry with core competencies in modern biosciences including the life sciences, consumer protection, healthcare and associated technological fields.
Home Main Navigation
End Main Navigation
for Companies and Research Institutions